32 Days
Source:
المشهد العربي
Bayer partially sells litigation unit
German company Bayer has finalized a deal to sell a minority stake in its contraceptive unit for 3 billion euros ($3.4 billion), while retaining operational control over the new entity, which achieved sales of 1.4 billion euros in 2025. The proceeds from the deal will be used to cover financial burdens resulting from litigation related to the herbicide "Roundup," as Bayer announced provisions for legal claims amounting to 11.8 billion euros. The company previously secured $8 billion in funding to settle these legal issues. This move aims to support the restructuring strategy led by CEO Bill Anderson to improve the company’s financial position.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)